Trial intelligence / Profile preview

Influence of long-acting local anesthetic infiltration analgesia on surgical wound healing

ChiCTR2300070216Phase 4Not yet recruiting

Sponsor
Peking Union Medical College Hospital
Start
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bupivacaine in postoperative pain (4 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Total Sufentanil Dosage 48 hours after surgery. Planned start Apr 2023; status: not yet recruiting.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2300070216.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300070216.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call